SimranSekhonMD

Oncology • Santa Monica, CA

Gastrointestinal Cancer, Hematologic Oncology, Hospice & Palliative

Attending physician

Join to view full profile

Dr. Sekhon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sekhon's full profile

Already have an account?

Office
2811 Wilshire Blvd
Santa Monica, CA 90403
Phone+1 310-552-9999
Is this information wrong?

Education & Training

University of TennesseeFellowship, Hematology and Medical Oncology, 2022 - 2025
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hospice and Palliative Medicine, 2019 - 2020
San Joaquin General HospitalResidency, Internal Medicine, 2011 - 2014
Manipal College of Medical ScienceClass of 2008

Certifications & Licensure

CA State Medical License 2013 - 2025
FL State Medical License 2021 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hospice and Palliative Medicine

Publications & Presentations

PubMed

13 citations
Isolated pulmonary valve endocarditis: truth or myth?
Siamak M. Seraj, Evanpaul Gill, Simranjit Sekhon> ;Journal of Community Hospital Internal Medicine Perspectives. 2017 Oct 18

Abstracts/Posters

FDA authorized treatment protocol using Deltarex-G as an adjuvant/first line therapy for early-stage, triple-negative metaplastic breast cancer
Gordon E, Adnan N, Sekhon S, Kim T, Welch S, Reed RA, Hall FL, Chawla SP:, San Antonio Breast Cancer Symposium, San Antonio, Texas, 12/2021
Preliminary Efficacy from an ongoing Phase 1 dose escalation study of Seclidimistat (SP-2577) in patients with advanced sarcomas and other solid tumors
Sant P. Chawla, Victoria S. Chua-Alcala, Jasgit C. Sachdev, David S. Wages, David D. Stenehjem, Daniela Y. Santiesteban, Nadeem Q. Mirza, Simranjit Sekhon, Erlinda M. ..., CTOS, Toronto, Canada, 11/2021
A Phase 2 study of Talimogene Laherparepvec, Nivolumab, and Trabectedin (TNT) in Advanced Sarcoma
Chawla SP, Kim T, Adnan N, Sekhon S, Chua V, Moradkhani A, Bhuiyan I, Quon D, Gordon EM, CTOS, Toronto, Canada, 11/2021
) Phase 1, open label, safety study of escalating doses of Ex Vivo, expanded, Autologous Natural Killer Cells in patients with Pathologically confirmed cancer refracto...
Chawla SP, Sekhon S, Adnan N, Chua-Alcala V, Quon D, Moradkhani A, Kim T, Cha S, Gordon EM, CTOS, Toronto, Canada, 11/2021
Join now to see all

Hospital Affiliations

Sutter Tracy Community HospitalTracy, California